Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daptomycin for Catheter-Related S. aureus Bloodstream Infections
NCT00507247Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- May 2006
- Primary completion
- Oct 2007
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of daptomycin in Staphylococcus aureus bacteremia (SAB), sponsored by University of Texas MD Anderson Cancer Center. Started May 2006; status: completed.
02
Drugs
daptomycin
03
Conditions
Staphylococcus aureus bacteremia (SAB)
Beyond the preview
Go deeper on NCT00507247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00507247.